Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THULITE: Oral BI 1815368 for Centre-involved Diabetic Macular Edema
jRCT2031250338Recruiting
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 2025
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in diabetic macular edema (DME) comparing BI 1815368 with Placebo (2 arms). Primary endpoint: Proportion of participants with ≥10-letter ETDRS BCVA gain at Week 48. Started Dec 2025; status: recruiting.
02
Drugs
BI 1815368
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on jRCT2031250338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031250338.